SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

SNDX is currently covered by 11 analysts with an average price target of $35.39. This is a potential upside of $14.6 (70.23%) from yesterday's end of day stock price of $20.79.

Syndax Pharmaceuticals's activity chart (see below) currently has 67 price targets and 72 ratings on display. The stock rating distribution of SNDX is 96.97% BUY and 3.03% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.22% with an average time for these price targets to be met of 228.53 days.

Highest price target for SNDX is $43, Lowest price target is $23, average price target is $35.39.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 28-Mar-2024. First documented stock forecast 31-Mar-2016.

Currently out of the existing stock ratings of SNDX, 32 are a BUY (96.97%), 1 are a HOLD (3.03%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

41

$20.21 (97.21%)

41

29 days ago

6/17 (35.29%)

$17.2 (72.27%)

606

Hold

23

$2.21 (10.63%)

36

2 months 26 days ago

1/3 (33.33%)

$2.51 (12.25%)

23

Buy

36

$15.21 (73.16%)

37

6 months ago

0/2 (0%)

$23.33 (184.14%)

Buy

38

$17.21 (82.78%)

33

6 months 9 days ago

0/4 (0%)

$25.64 (207.44%)

Buy

30

$9.21 (44.30%)

6 months 15 days ago

0/1 (0%)

$16.86 (128.31%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 228.53 days on average for the stock forecasts to be realized with a an average price target met ratio 29.22

Which analyst has the current highest performing score on SNDX (Syndax Pharmaceuticals) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Michael Schmidt with highest potential upside - $22.21

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

David Lebowitz with lowest potential downside - $0.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?